Glydways Stock

glydways.comTransportation / Autonomous VehiclesFounded: 2016Funding to Date: $65.94MM

Glydways is developing treatments for chronic inflammatory diseases using computationally designed antibodies.

Register for Details

For more details on financing and valuation for Glydways, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Glydways.

Register Today

Other companies like Glydways in the Autonomous Vehicles sector

Sector
Last Round Est. Valuation
$30B
Sector
Last Round Est. Valuation
$507.23MM
Sector
Last Round Est. Valuation
$5.68B
Sector
Last Round Est. Valuation
$8.64B
Sector
Last Round Est. Valuation
$93MM
Sector
Last Round Est. Valuation
$310.82MM
Sector
Last Round Est. Valuation
$2.57B
Updated on: Oct 3, 2023

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.